Can a Ohio resident get peptides by telehealth?
ORC 4743.09 (originally enacted by House Bill 122, effective March 23, 2022; current version effective April 9, 2025) lets licensed health care professionals provide telehealth services, including initial and annual visits, using synchronous or asynchronous technology when the appropriate standard of care for the visit is satisfied. The State Medical Board's rule OAC 4731-37-01 (effective February 28, 2023) applies this to physicians and physician assistants, holds telehealth to the in-person standard of care, permits synchronous or asynchronous communication technology if that standard can be met for the patient's condition, requires a medical evaluation completed through interaction with the patient, and allows non-controlled prescription drugs to be prescribed through telehealth under the rule's requirements. The prescriber must hold an Ohio license. None of the peptides in this database are controlled substances. This record classifies asynchronous prescribing as allowed because both the statute and the Medical Board rule expressly permit asynchronous technology for an initial visit and the rule permits non-controlled prescribing through telehealth. Neither text says whether a questionnaire alone is enough. [2] [3]
How does the Ohio pharmacy board treat compounding?
| Board | State of Ohio Board of Pharmacy |
|---|---|
| Eligible substances | Follows the federal 503A framework |
The Board of Pharmacy licenses pharmacists and terminal distributors of dangerous drugs (which includes pharmacies) under ORC chapter 4729 and regulates pharmacy compounding through OAC chapter 4729:7-2 and prescriber compounding through OAC chapter 4729:7-3. On July 17, 2025 the Board issued GLP-1 compounding guidance with FAQs for licensees. It states that pharmacy and prescriber compounding of copies of tirzepatide ended February 18, 2025 and of semaglutide ended April 22, 2025; that retatrutide and cagrilintide cannot be used in compounding under federal and state law, with any inventory to be disposed of immediately; that research use only products may never be used for compounding; and that pharmacies, clinics, and outsourcing facilities in Ohio must buy all active ingredients from Ohio-licensed drug distributors. Ohio has no state bulks list beyond these positions; peptide eligibility follows the federal 503A framework. ORC 4729.54 directs the Board to license terminal distributors whether located within or outside Ohio, and OAC 4729:5-8-02 sets licensure requirements for nonresident pharmacies, including proof of a valid home-state license and the most recent inspection report. Starting February 1, 2027, amended OAC 4729:5-2-01 requires the responsible person on an Ohio terminal distributor license held by a clinic or med spa to work at least 8 hours a month at the licensed location or make a documented quarterly on-site visit (Board of Pharmacy guidance updated September 10, 2026). [1] [4] [5] [6] [7] [8] [14]
Can you get compounded GLP-1s in Ohio?
Compounded semaglutide and tirzepatide are limited to the federal exception for documented patient specific needs because the FDA shortage allowances ended in 2025, and the Ohio Board of Pharmacy's July 2025 GLP-1 FAQs reinforce that copies of the approved products are not routinely compoundable in Ohio. Ohio's telehealth rule permits asynchronous technology when the in-person standard of care can be met and requires a medical evaluation completed through interaction with the patient. [3] [4] [11]
Prices by channel: semaglutide cost, tirzepatide cost.
Approvals, shortage history, and prices for every GLP-1 we track are on the GLP-1 hub.
What is the legal access path in Ohio?
Access options
Prescriber licensed in Ohio, in person or by telehealth
Telehealth prescribing of non-controlled peptides is permitted in Ohio. A prescriber may prescribe without a live visit (asynchronous care) when it meets the standard of care.
Pharmacy licensed or registered with the State of Ohio Board of Pharmacy
Check the dispensing pharmacy against the board's license lookup before paying, including out-of-state mail-order pharmacies.
Branded GLP-1 through a retail or manufacturer pharmacy
FDA approved semaglutide and tirzepatide are available by prescription. Compounded GLP-1 limited; see the GLP-1 section for why.
CJC-1295 / Ipamorelin from Bodybuilding Peptides
SponsoredPartner lists from $220/month
Tesamorelin / Ipamorelin from Bodybuilding Peptides
SponsoredPartner lists from $274/month
Semax / Selank from Bodybuilding Peptides
SponsoredPartner lists from $274/month
We may earn a commission from these links.
Prices are the partner's own and are not verified by PeptideAgent. You answer health questions after checkout, and the partner's clinician decides whether to prescribe.
Unsponsored access paths are checked against public regulatory records. Sponsored offers are the partner's and are labeled. Products labeled research use only are never listed.
Find a provider in Ohio
What you'll actually find in Ohio, and how to check
Licensed compounding pharmacies, clinics, and telehealth prescribers openly offer many unapproved peptides, and prescribers write prescriptions for them. [17] [18] [19]
No FDA oversight of the specific product: FDA does not check a compounded drug's safety, effectiveness, or quality before it is sold. [20]
What Ohio has done
PeptideAgent has not found a board or legislative action on peptides in Ohio.
Other states have acted:
- On August 19, 2026, Mississippi's medical, nursing, and pharmacy boards said no licensed provider may prescribe, recommend, supply, or administer a peptide that is not FDA approved, and that a consent form does not remove the provider's liability. [22] Mississippi law
- Louisiana acted by statute: Act 374, in effect August 1, 2026, bars its licensing boards from prohibiting peptides only when they come from a pharmacy or outsourcing facility that complies with federal compounding law. It does not make any peptide eligible to compound. [23] [24] Louisiana law
Checking the prescriber
Telehealth prescribing of non-controlled peptides is permitted in Ohio. A prescriber may prescribe without a live visit (asynchronous care) when it meets the standard of care. [2] [3] The telehealth rule in full.
Checking the pharmacy
Look the pharmacy up yourself before you pay, including an out-of-state mail-order pharmacy. The pharmacy regulator is the State of Ohio Board of Pharmacy; its license search: FDA BeSafeRx: state board of pharmacy license lookups. [21]
If you're going ahead anyway
These steps lower some risks. They do not make a compounded product safe, and FDA has not reviewed it. [20]
They do not change a peptide's legal status either. That depends on the peptide: for a withdrawn nomination such as BPC-157 or TB-500, a 503A pharmacy has no federal basis to compound it from bulk, with or without a prescription, while a few Category 1 substances, such as NAD+ and glutathione, are compounded under FDA's interim policy, with conditions. Each peptide page gives its status. [9] [25] [26]
Check the pharmacy's license. Look the pharmacy up yourself on your state board of pharmacy's license search; FDA's BeSafeRx page links every state's. If the pharmacy is not listed, or is not licensed in your state, do not use it. [21] [27] [28]
What a legitimate prescription and consult look like. Federal law lets a pharmacy compound only for an identified patient on a valid prescription. A legitimate prescriber is licensed in the state where you are, evaluates you, and tells you the drug is compounded and not FDA approved, and a telehealth company should say which pharmacy compounds it. A seller that needs no prescription, or a pharmacy with no pharmacist to answer questions, is a warning sign. [19] [28] [29]
Why this is safer than a research-use-only product. A state-licensed pharmacy answers to its state board and has a pharmacist you can reach. A product labeled "research use only" or "not for human consumption" has neither, and FDA treats such products sold for people as unapproved drugs. In a 2024 study of semaglutide sold online without a prescription, half of six orders never arrived, and every vial that did was rated probably substandard or falsified, held more drug than its label said, and contained endotoxin. Black-market growth peptides have also contained modified molecules the label did not name. Safer is not safe: compounded drugs can also be contaminated or have too much or too little active ingredient. [20] [30] [31] [32] [33] [34]
Check for:
- A 503A pharmacy licensed in your state (your state board of pharmacy publishes license lookups). [20]
- A real evaluation by a licensed prescriber, not just an online form.
- A certificate of analysis for the specific batch.
Questions to ask
- Pharmacy: What is your license number, and are you licensed in my state? Then check it yourself on the state board's site. [21]
- Telehealth company: Which pharmacy compounds and ships this, and is it a 503A pharmacy or a 503B outsourcing facility? [19]
- Pharmacy: Is this made for me on a prescription written in my name? [29]
- Prescriber: Are you licensed where I am, and will you evaluate me yourself rather than rely on a questionnaire? [19] [28]
- Anyone offering it: Does anyone call it "FDA approved", "generic", or from an "FDA-approved pharmacy"? None of these is true of a compounded drug, so the claim is a red flag. [19]
What is offered for a specific peptide, and what FDA found, is on each peptide page.
Is it legal to buy research peptides in Ohio?
ORC chapter 4729 restricts the sale and distribution of dangerous drugs to licensed pharmacies, distributors, and prescribers, and the Board reminds licensees to verify that sellers are licensed. Board guidance for prescriber clinics and medical spas (updated December 8, 2025) says any drug labeled for research purposes only is unlawful for a clinic or med spa to possess, even with patient consent, and must be disposed of immediately, with patients advised to stop using it. [1] [5] [12] [13]
Peptide-specific notes for Ohio
| Peptide | Note |
|---|---|
| Semaglutide | Available branded by prescription, including through synchronous or asynchronous telehealth under ORC 4743.09. The Ohio Board of Pharmacy's July 2025 GLP-1 FAQs and the end of the federal grace period on April 22, 2025 leave compounded semaglutide limited to documented patient specific needs. [2] [3] [4] [11] |
| Tirzepatide | Available branded by prescription. Compounded tirzepatide is limited to the federal patient specific exception since February 18, 2025, and the Ohio Board's GLP-1 FAQs address it directly. [4] [11] |
| Retatrutide | Investigational and not FDA approved. The Ohio Board of Pharmacy's July 17, 2025 GLP-1 guidance states that retatrutide cannot be used in compounding under federal and state law and that licensees found compounding, selling, or administering it may face discipline, including summary suspension. [4] [11] |
Compare: Semaglutide vs retatrutide, Wegovy vs Zepbound, Retatrutide vs tirzepatide.
Frequently asked questions
Can I get a GLP-1 prescription in Ohio through asynchronous telehealth?
Yes, if the prescriber holds an Ohio license and the in-person standard of care can be met. ORC 4743.09 and OAC 4731-37-01 allow synchronous or asynchronous technology, including for initial visits, and non-controlled drugs like semaglutide may be prescribed through telehealth. The rule also requires a medical evaluation completed through interaction with the patient. Neither text says whether a questionnaire alone is enough. [2] [3]
What does the Ohio Board of Pharmacy say about compounded GLP-1s?
In July 2025 the Board published GLP-1 compounding FAQs for licensees explaining how state and federal law apply after the FDA shortages ended. They treat copies of approved semaglutide and tirzepatide as no longer routinely compoundable. [4]
Is compounded semaglutide or tirzepatide still available in Ohio?
Only in limited, patient specific cases. The federal shortage allowances ended in 2025, and the Ohio Board of Pharmacy's FAQs reinforce that compounded copies are not a routine option. [4] [11]
Can an Ohio pharmacy compound retatrutide or BPC-157?
Retatrutide is an investigational drug, and the Ohio Board of Pharmacy's July 2025 GLP-1 guidance states that it cannot be used in compounding under federal and state law. BPC-157 is not FDA approved or on the 503A bulks list. A draft HHS enforcement discretion policy released October 28, 2026 covers only single-ingredient BPC-157 compounded by a state-licensed pharmacy by an allowed route, on a patient-specific prescription, from an FDA-registered manufacturer's tested substance, with serious adverse events reported to FDA; it is not an FDA approval, is not binding, and does not cover blends. Ohio law still applies. [4] [9] [10] [15] [16]
How do I check that a pharmacy is licensed to serve Ohio?
Search the Ohio eLicense system for the pharmacy's terminal distributor license from the State of Ohio Board of Pharmacy. Sellers without an Ohio license are not lawful sources of prescription drugs in Ohio. [1] [5]
Sources
Numbered citations above point to these primary sources: the state statute or rule, the pharmacy board, federal FDA guidance, and the FDA warning letters and studies behind what is offered.
- [1]State of Ohio Board of Pharmacy
- [2]Ohio Revised Code 4743.09, Telehealth services
- [3]Ohio Administrative Code 4731-37-01, Telehealth (State Medical Board of Ohio)
- [4]State of Ohio Board of Pharmacy: Compounding of GLP-1 drug products in Ohio, guidance and FAQs (issued July 17, 2025)
- [5]Ohio Revised Code chapter 4729, Pharmacists; dangerous drugs
- [6]Ohio Revised Code 4729.54, Terminal distributor licenses
- [7]Ohio Administrative Code 4729:5-8-02, Non-resident pharmacies: licensure
- [8]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
- [9]FDA: Certain bulk drug substances for use in compounding may present significant safety risks (503A and 503B category lists)FDA
- [10]FDA: Pharmacy Compounding Advisory CommitteeFDA
Cite this page
Free to cite and quote with a link. Data is licensed CC BY 4.0 with attribution to PeptideAgent.
- APA style
PeptideAgent. (2026, October 28). Are peptides legal in Ohio?. https://peptideagent.ai/legal/ohio- HTML link
<a href="https://peptideagent.ai/legal/ohio">Are peptides legal in Ohio?</a>, PeptideAgent, updated October 28, 2026.